2018
DOI: 10.15252/embr.201845889
|View full text |Cite
|
Sign up to set email alerts
|

TMEM 41B is a novel regulator of autophagy and lipid mobilization

Abstract: Autophagy maintains cellular homeostasis by targeting damaged organelles, pathogens, or misfolded protein aggregates for lysosomal degradation. The autophagic process is initiated by the formation of autophagosomes, which can selectively enclose cargo via autophagy cargo receptors. A machinery of well-characterized autophagy-related proteins orchestrates the biogenesis of autophagosomes; however, the origin of the required membranes is incompletely understood. Here, we have applied sensitized pooled CRISPR scr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

10
142
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 136 publications
(153 citation statements)
references
References 51 publications
10
142
1
Order By: Relevance
“…As in our study, these screens were performed using cells expressing fluorescently-tagged LC3 or autophagy receptors such as SQSTM1, NPD52, TAX1BP1 or NBR1. All of these screens resulted in the identification of novel candidates, most notably the ER protein TMEM41B, which was shown to participate in autophagosome biogenesis [68] [69] [70]. Our screen differed from previous ones in that we used cells expressing endogenously-tagged LC3B, thus avoiding artifacts of overexpression.…”
Section: Comparison To Previous Crispr/cas9 Ko Screensmentioning
confidence: 99%
“…As in our study, these screens were performed using cells expressing fluorescently-tagged LC3 or autophagy receptors such as SQSTM1, NPD52, TAX1BP1 or NBR1. All of these screens resulted in the identification of novel candidates, most notably the ER protein TMEM41B, which was shown to participate in autophagosome biogenesis [68] [69] [70]. Our screen differed from previous ones in that we used cells expressing endogenously-tagged LC3B, thus avoiding artifacts of overexpression.…”
Section: Comparison To Previous Crispr/cas9 Ko Screensmentioning
confidence: 99%
“…However, recent studies have increasingly emphasized the existence of systems controlling and executing autophagy in mammalian cells that are quite different from those in yeast [3]. Among wellaccepted examples, are several autophagy factors absent in yeast that have been identified in organisms from C. elegans to H. sapiens, including ATG101 [4], FIP200 [5], VMP1 [6], EPG5 [7], Stx17 [8,9], and TMEM41B [10][11][12].…”
Section: Introductionmentioning
confidence: 99%
“…As such, it provides an opportunity to uncover new information about the regulation of protein secretion. Pooled CRISPR screening has been used for a wide range of applications, including the investigation of drug-resistance mechanisms in cancer cells 9 , the genetics of pluripotency 10 , autophagy regulators 11,12 and host factors required for viral infection 13 . We previously demonstrated that unbiased pooled genome-wide CRISPR screening could effectively reveal key players required for glycoprotein secretion, using galectin-3 retention at the cell surface to assess glycoprotein secretion 14 .…”
Section: Introductionmentioning
confidence: 99%